102 related articles for article (PubMed ID: 4113201)
1. Adrenergic blockade in hypertension.
Lewis PJ; George CF; Dollery CT
Lancet; 1972 Jun; 1(7762):12232-3. PubMed ID: 4113201
[No Abstract] [Full Text] [Related]
2. The treatment of arterial hypertension with a new alpha-blocker, indoramin.
Carballo R; Conde L; Lapelle M; Suarez J
Curr Med Res Opin; 1974; 2(8):437-43. PubMed ID: 4155664
[No Abstract] [Full Text] [Related]
3. Cardiovascular actions of Wy 21901, a new hypotensive and anti-arrhythmic agent.
Alps BJ; Johnson ES; Wilson AB
Br J Pharmacol; 1970 Sep; 40(1):151P-152P. PubMed ID: 4395083
[No Abstract] [Full Text] [Related]
4. Human pharmacology of indoramin.
Coltart DJ; Lockhart JD; Royds RB; Turner P
Br J Pharmacol; 1971 Oct; 43(2):467P-468P. PubMed ID: 4400576
[No Abstract] [Full Text] [Related]
5. Antihypertensive effect of labetalol, a new alpha- and beta-adrenergic blocking agent.
Hansson L; Hänel B
Int J Clin Pharmacol Biopharm; 1976 Oct; 14(3):195-8. PubMed ID: 12115
[TBL] [Abstract][Full Text] [Related]
6. Double blind controlled trial of indoramin in the treatment of essential hypertension.
Dollery DT; George DG; Lewis PJ
Br J Pharmacol; 1972 Nov; 46(3):542P-543P. PubMed ID: 4571183
[No Abstract] [Full Text] [Related]
7. Adrenergic blockade in hypertension.
Lancet; 1972 May; 1(7760):1125-6. PubMed ID: 4112608
[No Abstract] [Full Text] [Related]
8. Comprehensive drug management of hypertension.
Oparil S; Winternitz S
Cardiovasc Clin; 1984; 14(3):73-91. PubMed ID: 6144392
[No Abstract] [Full Text] [Related]
9. Autonomic blocking properties of Wy 21901.
Alps BJ; Hill M; Johnson ES; Wilson AB
Br J Pharmacol; 1970 Sep; 40(1):153P. PubMed ID: 4395084
[No Abstract] [Full Text] [Related]
10. Proceedings: Initial clinical experience with indoramin, a new antihypertensive agent.
Royds RB
Br J Pharmacol; 1972 Feb; 44(2):379P-380P. PubMed ID: 4668635
[No Abstract] [Full Text] [Related]
11. Pharmacologic studies of indoramin in man.
Royds RB; Coltart DJ; Lockhart JD
Clin Pharmacol Ther; 1972; 13(3):380-92. PubMed ID: 4402080
[No Abstract] [Full Text] [Related]
12. Clinical evaluation of indoramin as the sole agent for the treatment of hypertension.
Kramer R; Rosendorff C; Bloom D
S Afr Med J; 1974 Aug; 48(37):1569-72. PubMed ID: 4851044
[No Abstract] [Full Text] [Related]
13. Prevention of exercise-induced asthma by indoramin.
Bianco S; Griffin JP; Kamburoff PL; Prime FJ
Br Med J; 1974 Oct; 4(5935):18-20. PubMed ID: 4154121
[TBL] [Abstract][Full Text] [Related]
14. [Various types of beta-receptor blockers in clinical anesthesia. 3. Pindolol (LB-46)].
Miyazaki M; Fujita T
Masui; 1971 Jul; 20(7):589-97. PubMed ID: 4397813
[No Abstract] [Full Text] [Related]
15. Treatment of high blood pressure. From diuretics to the present and future.
Nogueira da Costa J
Cardiologia; 1995 Dec; 40(12):893-8. PubMed ID: 8901039
[No Abstract] [Full Text] [Related]
16. Treatment of essential hypertension with a new vasodilator in combination with beta-adrenergic blockade.
Gilmore E; Weil J; Chidsey C
N Engl J Med; 1970 Mar; 282(10):521-7. PubMed ID: 4391708
[No Abstract] [Full Text] [Related]
17. Proceedings: Alpha-adrenoceptor inhibition from indoramin in man.
Boakes AJ; Prichard BN; Teoh PC
Br J Pharmacol; 1972 Feb; 44(2):378P-379P. PubMed ID: 4148923
[No Abstract] [Full Text] [Related]
18. Alpha-adrenergic blockade in severe asthma.
Utting JA
Br J Dis Chest; 1979 Jul; 73(3):317-8. PubMed ID: 45254
[TBL] [Abstract][Full Text] [Related]
19. [Silodosin. From research to clinical application: the activity, safety and long-term effectiveness].
Russo A; Hedlund P; Montorsi F
Urologiia; 2012; (4):104-6, 108-9. PubMed ID: 23116035
[No Abstract] [Full Text] [Related]
20. [On several anti-hypertensive drugs with special reference to the association of dihydroergocristine, reserpine and clopamide].
Martinetti L; Lai G
Arch Maragliano Patol Clin; 1970; 26(3):209-18. PubMed ID: 5002193
[No Abstract] [Full Text] [Related]
[Next] [New Search]
